A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants.
J Pediatr Gastroenterol Nutr
; 44(2): 245-51, 2007 Feb.
Article
in En
| MEDLINE
| ID: mdl-17255839
ABSTRACT
BACKGROUND:
Lactoferrin has an array of biological activities that include growth, immune modulation, and antimicrobial effects. The aim of this randomized, placebo-controlled, double-blind study was to examine the impact of bovine lactoferrin supplementation in infants. PATIENTS ANDMETHODS:
Healthy, formula-fed infants, > or =34 weeks' gestation and < or =4 weeks of age, enrolled in a pediatric clinic. Infants received either formula supplemented with lactoferrin (850 mg/L) or commercial cow milk-based formula (102 mg/L) for 12 months. Growth parameters and information on gastrointestinal, respiratory, and colic illnesses were collected for the infants' first year. Antibodies to immunizations and hematologic parameters were measured at 9 and 12 months.RESULTS:
The lactoferrin-enhanced formula was well tolerated. There were significantly fewer lower respiratory tract illnesses, primarily wheezing, in the 26 lactoferrin-fed (0.15 episodes/y) compared with the 26 regular formula-fed (0.5 episodes/y) infants (P < 0.05). Significantly higher hematocrit levels at 9 months (37.1% vs 35.4%; P < 0.05) occurred in the lactoferrin-supplemented group compared with the control formula group.CONCLUSIONS:
Lactoferrin supplementation was associated with potentially beneficial outcomes such as significantly fewer lower respiratory tract illnesses and higher hematocrits. Larger, more focused studies in infants are warranted.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bottle Feeding
/
Child Development
/
Dietary Supplements
/
Infant Formula
/
Lactoferrin
Type of study:
Clinical_trials
Limits:
Animals
/
Female
/
Humans
/
Infant
/
Male
/
Newborn
Language:
En
Journal:
J Pediatr Gastroenterol Nutr
Year:
2007
Document type:
Article
Affiliation country:
United States